Skip to main content

Table 1 Effects of AA and three different doses Lactobacillus plantarum ATCC8014 of prevention groups and therapeutic groups on oxidative stress parameters in 5 tissues of rats

From: Protective effect of Lactobacillus plantarum ATCC8014 on acrylamide-induced oxidative damage in rats

 

Treatment design

Hippocampus

Cerebellar

Liver

Small intestine

Kidney

LPO (μmol/gprot)

Control

24.17 ± 1.93a

14.04 ± 1.57a

17.51 ± 3.35a

34.54 ± 5.43a

34.80 ± 1.23a

AA

48.18 ± 3.85b

52.22 ± 4.33b

43.76 ± 2.68b

70.89 ± 3.22b

83.29 ± 4.20b

109 + AA

21.89 ± 2.03a

29.46 ± 3.21ab

22.40 ± 2.11a

38.71 ± 3.78a

59.89 ± 5.32a

108 + AA

27.36 ± 1.24a

33.48 ± 2.8ab

24.10 ± 2.34a

44.15 ± 3.13a

62.97 ± 2.33a

107 + AA

30.04 ± 1.94a

43.78 ± 1.76b

33.51 ± 3.06ab

54.12 ± 4.41ab

67.16 ± 4.58a

AA + 109

31.20 ± 3.91ab

27.90 ± 1.23ab

20.55 ± 1.61a

39.02 ± 4.35a

44.38 ± 2.44a

AA + 108

40.02 ± 3.52ab

36.38 ± 2.81ab

24.82 ± 1.31a

44.48 ± 1.46ab

44.58 ± 2.67a

AA + 107

44.39 ± 3.51b

46.41 ± 2.34b

33.84 ± 1.07ab

59.67 ± 3.26ab

63.78 ± 4.03a

GSH (mg/gprot)

Control

7.77 ± 0.45a

13.76 ± 1.08a

9.88 ± 0.59a

7.13 ± 0.14a

12.20 ± 0.50a

AA

3.84 ± 0.41b

9.81 ± 0.83b

3.25 ± 0.67b

4.45 ± 0.33b

6.45 ± 0.27b

109 + AA

7.30 ± 0.31a

13.55 ± 1.39a

6.89 ± 0.71ab

5.96 ± 0.31ab

10.96 ± 0.57a

108 + AA

6.65 ± 0.35a

11.19 ± 1.10b

4.92 ± 0.06ab

5.27 ± 0.28ab

10.31 ± 0.37a

107 + AA

6.45 ± 0.28a

10.71 ± 0.85b

4.52 ± 0.21ab

4.69 ± 0.26b

8.71 ± 0.51ab

AA + 109

7.28 ± 0.40a

11.86 ± 1.06a

6.74 ± 0.23a

6.20 ± 0.33ab

10.85 ± 0.11ab

AA + 108

6.26 ± 0.24a

11.14 ± 0.22b

5.50 ± 0.13ab

6.07 ± 0.26ab

8.76 ± 0.15ab

AA + 107

5.99 ± 0.37a

10.32 ± 1.16b

5.00 ± 0.34ab

5.70 ± 0.19a

7.78 ± 0.58ab

SOD (U/mgprot)

Control

49.33 ± 0.89a

69.07 ± 0.82a

15.10 ± 0.40a

36.50 ± 0.63a

17.96 ± 0.67a

AA

33.53 ± 0.77b

37.96 ± 0.67b

9.67 ± 0.29b

17.60 ± 0.63b

15.86 ± 0.75b

109 + AA

43.37 ± 0.85a

60.91 ± 0.75ab

13.26 ± 0.65a

29.80 ± 0.92ab

13.30 ± 0.36a

108 + AA

39.74 ± 0.83ab

55.70 ± 0.87ab

12.31 ± 0.54ab

27.76 ± 0.72ab

15.93 ± 0.53ab

107 + AA

37.18 ± 0.99b

51.50 ± 0.59b

10.59 ± 0.53ab

25.30 ± 0.68b

14.48 ± 0.72b

AA + 109

42.67 ± 0.86ab

60.44 ± 0.91a

12.66 ± 0.63a

26.17 ± 0.68a

12.78 ± 0.54ab

AA + 108

38.97 ± 0.84b

53.94 ± 0.92ab

11.53 ± 0.47a

23.30 ± 0.70ab

11.33 ± 0.60ab

AA + 107

36.68 ± 0.74b

46.80 ± 1.02ab

10.55 ± 0.37ab

21.09 ± 0.95b

23.37 ± 0.70ab

CAT (U/mgprot)

Control

31.97 ± 1.16a

73.83 ± 0.74a

12.19 ± 0.73a

24.50 ± 0.84a

13.16 ± 0.83a

AA

17.30 ± 0.81b

25.88 ± 0.87b

4.48 ± 0.60b

8.92 ± 0.51b

6.19 ± 0.38b

109 + AA

28.56 ± 0.73a

59.52 ± 1.09a

10.49 ± 0.75ab

23.17 ± 0.75b

10.72 ± 0.91ab

108 + AA

26.55 ± 1.29a

55.59 ± 0.98a

7.76 ± 0.71ab

15.15 ± 0.62b

9.72 ± 0.38ab

107 + AA

23.94 ± 1.14ab

47.60 ± 1.31a

6.66 ± 0.48b

12.12 ± 0.76ab

8.94 ± 0.58ab

AA + 109

27.67 ± 0.55a

59.43 ± 0.75a

9.59 ± 0.74ab

21.81 ± 0.93a

10.49 ± 0.32a

AA + 108

24.67 ± 0.66ab

54.57 ± 0.52a

8.52 ± 0.51ab

15.02 ± 0.61a

9.26 ± 0.57ab

AA + 107

21.38 ± 0.91ab

44.38 ± 0.72b

5.53 ± 0.52b

10.64 ± 1.12a

8.35 ± 0.78ab

  1. Values are expressed as mean ± SD for 6 animals in each group. “a” values differ significantly from AA group (p < 0.05), no labeling represents no significant difference; “b” values differ significantly from control group (p < 0.05), no labeling represents no significant difference